GLP-1 hormone role in prediabetes
Part of Hormones & metabolism clinical trials.
This study looks at how a hormone called GLP-1, made in the pancreas, affects blood sugar levels in people with borderline high blood sugar (prediabetes). It may help find new ways to prevent diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 70 years old.
- Your weight has been stable, and you have never been diagnosed with diabetes.
- Your fasting blood sugar is less than 126 mg/dL.
- Your hemoglobin A1c (a 3-month blood sugar average) is less than 6.5%.
- You are not taking any diabetes medications.
- You have not had upper abdominal surgery (like gastric bypass).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how glucagon affects insulin release and blood sugar in people who do not have type 2 diabetes. It may help us understand normal glucose control better.
This trial tests whether a special GLP-1 formula drink can help control blood sugar and improve gut bacteria in people with prediabetes. It may offer a new way to manage early diabetes risk.
This study looks at how your genes may change how well a GLP-1–type medicine works to improve prediabetes. It focuses on adults at higher risk of developing diabetes, especially people of Mexican-American background.
This study tests whether a medication called Henagliflozin (a type of SGLT2 inhibitor) can help people with prediabetes return their blood sugar to normal. It is for adults who have not been treated for high blood sugar before.
This study tests whether intermittent fasting can improve how your body releases and uses insulin if you have prediabetes or early type 2 diabetes. It may help your blood sugar control without using insulin.
This study is looking at whether a specific gene type (rs7903146) affects how the pancreas produces a hormone called GLP-1, which helps control blood sugar. It may help explain why some people are more likely to develop diabetes.
Hear when a new Prediabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.